News
Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
June 18, 2010 8:37 am | by Bio-Medicine.Org | CommentsSAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City . The focus represents a growing interest and validation of how PEM can play an...
St. Jude Medical wins another CE Mark for cardiac ablation device
June 18, 2010 8:35 am | by Mass Device | CommentsSt. Jude Medical Inc. won another CE Mark from the European Union for a cardiac ablation device, this time for its cryogenic Therapy Cool Flex catheter. By Brandon Glenn St. Jude Medical Inc. (NYSE:STJ) won CE Mark approval in the European Union for a cryogenic cardiac ablation...
Zoll wins three-year AED contract in U.K.
June 18, 2010 8:35 am | by Mass Device | CommentsZoll Medical Corp. wins a three-year contract with Britain's national heart charity, the British Heart Foundation, to be its exclusive supplier of automated external defibrillators. Zoll Medical Corp. (NSDQ:ZOLL) landed a lucrative deal as the British Heart Foundation's...
Mylan Receives Approval for Generic Version of Zocor® Tablets
June 18, 2010 8:34 am | by Bio-Medicine.Org | CommentsPITTSBURGH , June 18 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg,...
Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
June 18, 2010 8:33 am | by Bio-Medicine.Org | CommentsROCKVILLE, Md. , June 18 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi , President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2010 conference on June 21 and June 22, 2010 at The...
St. Jude gets European approval for heart device
June 18, 2010 7:45 am | by The Associated Press | CommentsMedical device maker St. Jude Medical Inc. said Friday it received European regulatory approval for its Therapy Cool Flex Ablation Catheter, aimed treating irregular heartbeats.St. Jude's Therapy Cool is currently not approved in the U.S.Shares of St. Jude fell 3 cents to $37.77 in morning...
Medicare reimbursement cuts take effect
June 18, 2010 5:37 am | by Mass Device | CommentsStarting today, doctors face a 21 percent cut in Medicare reimbursement rates, after a Senate vote late June 17 to enact cuts mandated by sustainable growth rate legislation. The U.S. Senate voted late June 17 not to block a 21 percent reduction in Medicare reimbursement rates,...
MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men
June 18, 2010 4:34 am | by Boston Scientific | CommentsNATICK, Mass. and NICE, France, June 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical
Vitamin D deficiency confirmed as common across a range of rheumatic conditions
June 18, 2010 4:33 am | by EurekAlert | Comments(European League Against Rheumatism) Two separate studies have shown that vitamin D deficiency is common in patients with a range of rheumatic diseases, with over half of all patients having below the "normal" healthy levels of vitamin D (48-145 nmol/L) in their bodies. A further...
Genealogy may affect clinical differences in systemic lupus erythmatosus patients
June 18, 2010 12:35 am | by EurekAlert | Comments(European League Against Rheumatism) The effects of systemic lupus erythematosus (SLE) may differ based on the individual patient's genealogical heritage, according to results of a new study presented today at EULAR 2010, the Annual Congress of the European League Against...
Expression of certain transporter proteins may predict resistance to drug therapy
June 18, 2010 12:35 am | by EurekAlert | Comments(European League Against Rheumatism) The expression of a transporter protein called the breast cancer resistance protein in rheumatoid arthritis patients may indicate higher disease activity and could be a barrier to the effectiveness of disease-modifying antirheumatic drugs,...
TGen partner, PBS-Bio, makes first breakthrough drug analysis
June 18, 2010 12:33 am | by EurekAlert | Comments(The Translational Genomics Research Institute) Predictive Biomarker Sciences Inc. has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.
Women who consume large amounts of tea have increased risk of rheumatoid arthritis
June 18, 2010 12:33 am | by EurekAlert | Comments(European League Against Rheumatism) Women who drink tea have an increased risk of developing rheumatoid arthritis (RA) compared with those who drink none (p=0.04), according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in...
Partners grieve rheumatoid arthritis diagnosis as much as patients
June 18, 2010 12:33 am | by EurekAlert | Comments(European League Against Rheumatism) Partners of patients newly diagnosed with rheumatoid arthritis are equally emotionally affected by the diagnosis and go through the same grieving process as the patients themselves, according to the results of a study presented today at EULAR...
Investing in Banks of Stem Cells
June 17, 2010 9:37 pm | by Massachusetts Institute of Technology | CommentsScientists are creating collections of reprogrammed stem cells to use for transplants and drug testing.
